Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
500
Frequently Asked Questions
What is Market Cap of Corcept Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Corcept Therapeutics Inc market cap is $7.31B.
What is the 52-week high for Corcept Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Corcept Therapeutics Inc 52 week high is $117.33 as of September 05, 2025.
What is the 52-week low for Corcept Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Corcept Therapeutics Inc 52 week low is $33.66 as of September 05, 2025.
What is Corcept Therapeutics Inc stock price today?
Corcept Therapeutics Inc stock price today is $69.36.
What was Corcept Therapeutics Inc stock price yesterday?
Corcept Therapeutics Inc stock price yesterday was $69.37.
What is the PE ratio of Corcept Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Corcept Therapeutics Inc’s P/E ratio is 61.73.
What is the Price-to-Book ratio of Corcept Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Corcept Therapeutics Inc P/B ratio is 11.4877.
What is the 50-day moving average of Corcept Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Corcept Therapeutics Inc 50-day moving average is $70.76.
How many employess does Corcept Therapeutics Inc has?